Differential modulation by interferon γ of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens Alexei F. KirkinP. thor StratenJ. Zeuthen ORIGINAL ARTICLE Pages: 203 - 212
Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells M. Margaret PrechelYvonne LozanoM. R. I. Young ORIGINAL ARTICLE Pages: 213 - 220
Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2 M. J. EhrkeSrdan VerstovšekEnrico Mihich ORIGINAL ARTICLE Pages: 221 - 230
Involvement of tumor necrosis factor α and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis A. HigashiyamaHideaki WatanabeHideo Yagita ORIGINAL ARTICLE Pages: 231 - 236
Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes Marjorie J. ArcaJohn C. KraussA. E. Chang ORIGINAL ARTICLE Pages: 237 - 245
Identification of peptide epitopes of MAGE-1, -2, -3 that demonstrate HLA-A3-specific binding C. A. McIntyreRobert C. ReesAnna K. Murray ORIGINAL ARTICLE Pages: 246 - 250
An indicator quantitatively comparing two treatment effect sizes on responder and non-responder groups – exponential of estimated interaction parameter M. SugitaTakashi IzunoToshio Mitomi ORIGINAL ARTICLE Pages: 251 - 254
Intradermal administration of lipopolysaccharide in treatment of human cancer Shigenori GotoSumitaka SakaiShoshichi Takeuchi ORIGINAL ARTICLE Pages: 255 - 261
